Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Thor

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Oncogene|July 7, 2010
Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cellsP M Das, A D Thor, S M Edgerton, et al.
Breast Cancer Research and Treatment|January 1, 1992
pS2 expression in primary breast carcinomas: relationship to clinical and histological features and survivalA D Thor, F C Koerner, S M Edgerton, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1993
p53 gene mutations and protein accumulation in human ovarian cancerJ Kupryjańczyk, A D Thor, R Beauchamp, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 1, 1995
Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogeneL R Zukerberg, W I Yang, M Gadd, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 1, 1994
p53 expression in cutaneous malignant melanoma: an immunohistochemical study of 87 cases of primary, recurrent, and metastatic melanomaR L Barnhill, J S Castresana, M P Rubio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progressionC Wang, A D Thor, D H Moore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1994
Prognostic value of Cathepsin D expression in breast cancer: immunohistochemical assessment and correlation with radiometric assayP Eng Tan, C C Benz, C Dollbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2000
Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancerA D Thor, S Liu, S Edgerton, et al.
Cancer Research|January 15, 1991
pS2 expression and response to hormonal therapy in patients with advanced breast cancerL H Schwartz, F C Koerner, S M Edgerton, et al.
Oncogene|February 15, 2001
Ets regulation of the erbB2 promoterG K Scott, C H Chang, K M Erny, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Oncogene|July 7, 2010
Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cellsP M Das, A D Thor, S M Edgerton, et al.
Breast Cancer Research and Treatment|January 1, 1992
pS2 expression in primary breast carcinomas: relationship to clinical and histological features and survivalA D Thor, F C Koerner, S M Edgerton, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1993
p53 gene mutations and protein accumulation in human ovarian cancerJ Kupryjańczyk, A D Thor, R Beauchamp, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 1, 1995
Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogeneL R Zukerberg, W I Yang, M Gadd, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 1, 1994
p53 expression in cutaneous malignant melanoma: an immunohistochemical study of 87 cases of primary, recurrent, and metastatic melanomaR L Barnhill, J S Castresana, M P Rubio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progressionC Wang, A D Thor, D H Moore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1994
Prognostic value of Cathepsin D expression in breast cancer: immunohistochemical assessment and correlation with radiometric assayP Eng Tan, C C Benz, C Dollbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2000
Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancerA D Thor, S Liu, S Edgerton, et al.
Cancer Research|January 15, 1991
pS2 expression and response to hormonal therapy in patients with advanced breast cancerL H Schwartz, F C Koerner, S M Edgerton, et al.
Oncogene|February 15, 2001
Ets regulation of the erbB2 promoterG K Scott, C H Chang, K M Erny, et al.
Pageof 5